---
name: IVDR Performance-Evaluation Plan Blueprint
version: 0.1.0
description: Draft a comprehensive Performance‑Evaluation Plan (PEP) that satisfies Article 56 and Annex XIII of the IVDR.
metadata:
  domain: regulatory
  complexity: medium
  tags:
  - regulatory-strategy
  - ivdr
  - performance-evaluation
  - plan
  - blueprint
  requires_context: false
variables:
- name: device_details
  description: any additional device information
  required: true
model: gpt-4o-mini
modelParameters:
  temperature: 0.2
messages:
- role: system
  content: |-
    You are an EU IVDR subject‑matter expert employed by a Notified Body. Device: Class C immunoassay for cardiac biomarkers. Development starts Q3‑2025 with target CE submission Q3‑2026. The manufacturer operates an ISO 13485‑certified QMS.

    Draft a comprehensive Performance‑Evaluation Plan (PEP) that satisfies Article 56 and Annex XIII of the IVDR.
- role: user
  content: |-
    1. Structure the plan with numbered H2/H3 headings:
       - Device description and intended purpose.
       - Performance‑evaluation scope and objectives.
       - Scientific‑validity strategy.
       - Analytical‑performance studies (including MDCG 2022‑2 parameters).
       - Clinical‑performance studies or literature‑review methodology.
       - Statistical methods and acceptance criteria.
       - State‑of‑the‑art comparison.
       - Benefit‑risk determination.
       - Gantt‑style timeline (12‑month window).
       - Data ownership and update frequency.
    1. Embed the Gantt timeline as a Markdown table (quarters).
    1. Cite specific IVDR clauses or MDCG guidance used.
    1. Provide a short bullet list of risks and mitigations.
    1. Keep total length ≤1 500 words.

    Inputs:
    - `{{device_details}}` — any additional device information.

    Output format:
    Markdown document with the sections above, including tables where relevant.

    Additional notes:
    Present reasoning step‑by‑step and keep the language concise.
testData: []
evaluators: []
